These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37864550)

  • 21. Implementation of rapid antimicrobial susceptibility testing combined with routine infectious disease bedside consultation in clinical practice (RAST-ID): a prospective single-centre study.
    Valentin T; Koenig E; Prattes J; Wunsch S; Loizenbaur T; Krause R; Zollner-Schwetz I
    J Antimicrob Chemother; 2021 Jan; 76(1):233-238. PubMed ID: 33305799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.
    Matuschek E; Brown DF; Kahlmeter G
    Clin Microbiol Infect; 2014 Apr; 20(4):O255-66. PubMed ID: 24131428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vibrio species: development of EUCAST susceptibility testing methods and MIC and zone diameter distributions on which to determine clinical breakpoints.
    Karatuna O; Matuschek E; Åhman J; Caidi H; Kahlmeter G
    J Antimicrob Chemother; 2024 Feb; 79(2):375-382. PubMed ID: 38158720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of standardized automated rapid antimicrobial susceptibility testing of Enterobacterales-containing blood cultures: a proof-of-principle study.
    Mancini S; Bodendoerfer E; Kolensnik-Goldmann N; Herren S; Röthlin K; Courvalin P; Böttger EC
    J Antimicrob Chemother; 2020 Nov; 75(11):3218-3229. PubMed ID: 32766760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EUCAST rapid antimicrobial susceptibility testing (RAST) compared to conventional susceptibility testing: implementation and potential added value in a tertiary hospital in Belgium.
    Strubbe G; Messiaen AS; Vandendriessche S; Verhasselt B; Boelens J
    Acta Clin Belg; 2023 Oct; 78(5):385-391. PubMed ID: 36999562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of Rapid Antimicrobial Susceptibility Testing directly from blood cultures using WASPLab
    Herroelen PH; Heestermans R; Emmerechts K; Vandoorslaer K; Wybo I; Piérard D; Muyldermans A
    Eur J Clin Microbiol Infect Dis; 2022 May; 41(5):733-739. PubMed ID: 35217936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of EUCAST rapid antimicrobial susceptibility testing (RAST) on management of Gram-negative bloodstream infection.
    Cardot Martin E; Colombier MA; Limousin L; Daude O; Izarn O; Cahen P; Farfour E; Lesprit P; Vasse M
    Infect Dis Now; 2022 Nov; 52(8):421-425. PubMed ID: 36108973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study to reduce turnaround time of microbiologically positive blood cultures in patients with sepsis in intensive care unit.
    Siddiqui F; Gupta A; Purwar S; Saigal S; Sharma JP
    Indian J Med Microbiol; 2022; 40(4):541-546. PubMed ID: 36002357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applicability and performance of EUCAST's rapid antimicrobial susceptibility testing (RAST) on primarily sterile body fluids in blood culture bottles in laboratory routine with total lab automation.
    Jasuja JK; Zimmermann S; Burckhardt I
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1217-1225. PubMed ID: 33438162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
    Haldorsen B; Giske CG; Hansen DS; Helgason KO; Kahlmeter G; Löhr IH; Matuschek E; Österblad M; Rantakokko-Jalava K; Wang M; Småbrekke L; Samuelsen Ø; Sundsfjord A;
    J Antimicrob Chemother; 2018 Oct; 73(10):2738-2747. PubMed ID: 30053113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tentative breakpoints and areas of technical uncertainty for early reading automated disc diffusion for Enterobacterales.
    Mancini S; Röthlin K; Bodendoerfer E; Herren S; Kolesnik-Goldmann N; Courvalin P; Zbinden R; Böttger EC
    J Antimicrob Chemother; 2020 Jun; 75(6):1495-1505. PubMed ID: 32155259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination.
    Schön T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
    Clin Microbiol Infect; 2020 Nov; 26(11):1488-1492. PubMed ID: 32750539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of
    Shifman O; Aminov T; Aftalion M; Gur D; Cohen H; Bar-David E; Cohen O; Mamroud E; Levy H; Aloni-Grinstein R; Steinberger-Levy I; Rotem S
    Microorganisms; 2021 May; 9(5):. PubMed ID: 34068310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an In-House Rapid Antimicrobial Susceptibility Testing Protocol for Positive Blood Culture and Its Implementation in Routine Microbiology Laboratories.
    Cao M; Huang L; Hu Y; Fang Y; Zhang R; Chen G
    Front Microbiol; 2021; 12():765757. PubMed ID: 34917051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short incubation of disc diffusion for Streptococcus pneumoniae and Haemophilus influenzae to reduce time to susceptibility report.
    Åkerlund A; Serrander L; Sundqvist M
    J Antimicrob Chemother; 2023 Oct; 78(10):2563-2571. PubMed ID: 37667593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing.
    Matuschek E; Longshaw C; Takemura M; Yamano Y; Kahlmeter G
    J Antimicrob Chemother; 2022 May; 77(6):1662-1669. PubMed ID: 35289853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Test for
    Shan Y; Hu B; Guo W; Wang B; Zhou C; Huang S; Li N
    J Clin Microbiol; 2022 Apr; 60(4):e0255921. PubMed ID: 35354293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of EUCAST rapid antibiotic susceptibility breakpoints and screening cut-off values directly from blood cultures for the inference of β-lactam resistance mechanisms in Enterobacterales.
    Cerrudo V; Cortés-Cuevas JL; García-Fernández S; Morosini MI; Cantón R; Sánchez-Díaz AM
    JAC Antimicrob Resist; 2023 Feb; 5(1):dlad017. PubMed ID: 36816745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli.
    Leverstein-van Hall MA; Waar K; Muilwijk J; Cohen Stuart J;
    J Antimicrob Chemother; 2013 Nov; 68(11):2636-40. PubMed ID: 23766488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.